These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7457342)

  • 1. Mandatory PPIs to begin in 1981; APhA issues strong objections.
    Small WE
    Am Pharm; 1980 Nov; NS20(11):10-1. PubMed ID: 7457342
    [No Abstract]   [Full Text] [Related]  

  • 2. Will PPIs affect your patients' attitudes?
    Patient Care; 1979 Feb; 13(3):190-1, 195-6. PubMed ID: 10240261
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA commissioner discusses issues of concern to hospital pharmacists. Interview by William A. Zellmer.
    Goyan JE
    Am J Hosp Pharm; 1980 May; 37(5):738-40 contd. PubMed ID: 7386484
    [No Abstract]   [Full Text] [Related]  

  • 4. A means to provide patient education: "Rx package inserts, patient package inserts, device labeling".
    Sherman M
    ONA J; 1979 Aug; 6(8):326-9. PubMed ID: 257297
    [No Abstract]   [Full Text] [Related]  

  • 5. The legal status of patient package inserts.
    Whitman JA
    Hosp Formul; 1978 Oct; 13(10):789-91. PubMed ID: 10238809
    [No Abstract]   [Full Text] [Related]  

  • 6. Prescription drug products; patient labeling requirements: proposed rule.
    Fed Regist; 1979 Jul; 44(131 Pt 2):40015-41. PubMed ID: 10242793
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA acts on estrogen, progestin labeling.
    FDA Consum; 1977 Nov; 11(9):3. PubMed ID: 10305006
    [No Abstract]   [Full Text] [Related]  

  • 8. Estrogen PPIs. An FDA survey.
    Morris LA; Myers A; Gibbs P; Lao C
    Am Pharm; 1980 Jun; NS20(6):22-6. PubMed ID: 7395715
    [No Abstract]   [Full Text] [Related]  

  • 9. Sounding board. Creative tension: FDA and medicine.
    Kennedy D
    N Engl J Med; 1978 Apr; 298(15):846-50. PubMed ID: 345121
    [No Abstract]   [Full Text] [Related]  

  • 10. Some issues related to patient package inserts.
    Fink JL
    Hosp Formul; 1979 Feb; 14(2):181-3. PubMed ID: 10240143
    [No Abstract]   [Full Text] [Related]  

  • 11. The regulatory role of the United States Food and Drug Administration.
    Ortiz EM
    J Reprod Med; 1972 Apr; 8(4):205-6. PubMed ID: 5029971
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug labeling for teratogenicity: requirements of the U.S. Food and Drug Administration.
    Kelsey FO
    Prog Clin Biol Res; 1985; 163C():155-9. PubMed ID: 3991617
    [No Abstract]   [Full Text] [Related]  

  • 13. The history of patient package inserts in the United States.
    Moore SR; Morris LA; Groft SC
    Can Pharm J; 1981 May; 114(5):173-5. PubMed ID: 10251273
    [No Abstract]   [Full Text] [Related]  

  • 14. The patient package insert and its legal implications.
    Cook D
    Leg Med Q; 1980; 4():258-70. PubMed ID: 10258797
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient package inserts--instructions or intrusions?
    Harvey MW
    Leg Aspects Med Pract; 1978 Aug; 6(8):47-51. PubMed ID: 703481
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA in hot water again over cost of proposed drug labeling rule.
    Demkovich LE
    Natl J (Wash); 1979 Sep; 11(38):1568-70. PubMed ID: 10243426
    [No Abstract]   [Full Text] [Related]  

  • 17. Relative efficacy. When the government decides what drug should be prescribed, is the patient better served?
    J Med Assoc State Ala; 1972 Sep; 42(3):200-12. PubMed ID: 5070864
    [No Abstract]   [Full Text] [Related]  

  • 18. Professional drug labeling.
    Terry M
    J Am Vet Med Assoc; 1993 May; 202(10):1711-2;discussion 1713-7. PubMed ID: 8514591
    [No Abstract]   [Full Text] [Related]  

  • 19. Content and format for labeling for human prescription drugs; amendment of effective date for certain biological products--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(15 pt 1):7271-3. PubMed ID: 10249526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AVMA legislation: partial solution to drug availability problem.
    Gloyd JS
    J Am Vet Med Assoc; 1993 Apr; 202(7):1055-6. PubMed ID: 8473213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.